-
World’s top EV battery maker CATL files fresh infringement lawsuit, adds to China’s lengthy battery patent docket
Read more: World’s top EV battery maker CATL files fresh infringement lawsuit, adds to China’s lengthy battery patent docketContemporary Amperex Technology Co., Limited’s action marks its seventh patent infringement suit against local rival China Aviation Lithium Battery, with a cumulative claim of over 700 million Chinese yuan (US$ 95.6 million) in damages.
-
Netgear settles WiFi 6 standard-essential patent dispute with Huawei, takes license to Sisvel pool between Unified Patent Court and Munich I Regional Court rulings
Read more: Netgear settles WiFi 6 standard-essential patent dispute with Huawei, takes license to Sisvel pool between Unified Patent Court and Munich I Regional Court rulingsNetgear and Huawei have filed a motion to stay the U.S: litigation started by the router maker in response to enforcement actions in the UPC and German courts.
-
Europe’s 17% share of 5G standard-essential patents exceeds its companies’ automotive market shares in cars (16%) and dwarfs the one in smartphones (< 5%)
Read more: Europe’s 17% share of 5G standard-essential patents exceeds its companies’ automotive market shares in cars (16%) and dwarfs the one in smartphones (< 5%)A new 5G landscaping report named Patently100 has been released by the Patently service.
-
Unprecedented major delay at USITC for remedy recommendation after Lenovo was found to infringe four Ericsson SEPs
Read more: Unprecedented major delay at USITC for remedy recommendation after Lenovo was found to infringe four Ericsson SEPsWhile ITC judges typically issue their recommendations on remedy (i.e., U.S. import ban) near-simultaneously with their rulings, it will now potentially take more than two months in an Ericsson-Lenovo SEP case.
-
An interview with Johnson & Johnson’s departing VP of MedTech IP Strategy Paul Coletti
Read more: An interview with Johnson & Johnson’s departing VP of MedTech IP Strategy Paul ColettiIn this interview, Paul Coletti, (now former) VP of MedTech IP Strategy at Johnson & Johnson, shares the highlights of his 37 years in the company’s IP department, and the basis of successful leadership.
-
Huawei v. Netgear was only the second UPC anti-antisuit motion this month: a near-simultaneous one may have targeted Xiaomi
Read more: Huawei v. Netgear was only the second UPC anti-antisuit motion this month: a near-simultaneous one may have targeted XiaomiThe UPC’s Munich LD has now published its December 11, 2024 anti-antisuit injunction in Huawei v. Netgear. It turns out that a similar motion was brought in a different case slightly before Huawei’s filing.
-
Abbott fends off Dexcom’s push for patent royalties as multi-jurisdictional litigation settles with 10-year zero-zero patent peace over glucose monitoring devices
Read more: Abbott fends off Dexcom’s push for patent royalties as multi-jurisdictional litigation settles with 10-year zero-zero patent peace over glucose monitoring devicesAbbott and Dexcom have settled a multi-jurisdictional patent dispute over glucose monitoring devices. It appears that Dexcom failed to achieve its goal of getting Abbott to pay.
-
After almost 5 years of being sued by Broadcom, Netflix files U.S. countersuit over former HP virtualization patents: UPC filings to follow?
Read more: After almost 5 years of being sued by Broadcom, Netflix files U.S. countersuit over former HP virtualization patents: UPC filings to follow?Context: In the early phase of the COVID-19 pandemic, Broadcom (Avago) started to sue Netflix over video streaming patents (March 14, 2020 Variety article). Para. 20 of the complaint (PDF) alleges that Broadcom’s business of selling “semiconductor chips used in the set top boxes that enable traditional cable television services” was substantially and irreparably harmed…